This article from July last year has been posted before but serves as a reminder.
Nanodx gets $18M to pursue fast, easy COVID-19, TBI tests; aims for market shortly | 2020-07-02 | BioWorld
"Nanodx said that it already has partnered to get the SARS-CoV-2 test system to various outlets – such as airlines and sports leagues – that could use the device, which is about the size of a toaster."
As we know from previous SE1 company announcements:
2nd July: USD $2m worth of orders for development and delivery of the COVID sensor
6th October: USD $3m worth of orders for development and delivery of the COVID sensor
9th December: USD $10m in the pipeline for the COVID sensor
From Sensera's quarterly announcement on 28th Jan:
''Sensera has secured a manufacturing agreement predicated on FDA approval, which will be fully disclosed in the event that NanoDX receives the approval'.
With FDA EUA submission likely less than a month away (with an approval expected to be swiftly expedited), one can imagine quite a substantial update and growth of orders will be announced. What kind of market reaction will there be if SE1 (currently a $25m MC) announces USD $5m worth of COVID sensor orders? What about USD $10m+?
This is the calm before the storm. Interesting and exciting times ahead.
Cheers
- Forums
- ASX - By Stock
- SE1
- US $3m+ of COVID Detection Sensor Orders
US $3m+ of COVID Detection Sensor Orders, page-3
- There are more pages in this discussion • 151 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)